Skip Ribbon Commands
Skip to main content
Translate
Translate
menu iconMenu
search iconSearch

UCSD Researcher Awarded One of First-Ever NIH New Innovator Awards

 

September 19, 2007  |   

Jing Yang, Ph.D., an assistant professor of pharmacology and pediatrics at the University of California, San Diego (UCSD) School of Medicine, has been awarded a “New Innovator Award” by the NIH for her work to develop new approaches to studying how cancer cells metastasize to distant organs.  

Jing Yang, PhD
Jing Yang, PhD

“Novel ideas and new investigators are essential ingredients for scientific progress, and the creative scientists we recognize with NIH Director’s Pioneer Awards and New Innovator Awards are well-positioned to make significant – and potentially transformative – discoveries in a variety of areas,” said Elias A. Zerhouni, M.D., director of the NIH, in announcing the award winners at the NIH Director’s Pioneer Award Symposium in Washington, D.C. on September 19.

Innovative ideas by new scientific investigators like Yang have prompted Zerhouni, to make a major investment in the future of science. As one of 29 New Innovator Award recipients for 2007, Yang will receive $1.5 million in direct costs over five years to support her work.   

“Until recently, most fundamental studies of cancer biology focused on the earliest steps in tumor formation. However, the resulting primary tumors only rarely kill patients directly,” said Roger Y. Tsien, Ph.D., Howard Hughes Medical Institute Investigator and professor of Pharmacology at UCSD.   “Most cancer deaths result from metastases, in which a tiny minority of primary tumor cells manages to spread widely throughout the body and establish widespread secondary colonies.  Dr. Yang proposes to develop novel approaches to study those crucial disseminating ringleaders and find out what makes them so mobile and dangerous. We're delighted that the NIH has recognized such a promising young investigator with an exciting new strategy."

The NIH has announced that a total of more than $105 million will be awarded to 41 exceptionally innovative investigators – many of whom are in early stages of their research careers – as part of an NIH “Roadmap for Medical Research” initiative that tests new approaches to supporting research in the United States.

More than 2,100 applications were received for this extremely competitive program, which recognizes bold ideas from some of the nation's most innovative new scientists.  In addition to the 29 “Innovator” awards, reserved for new investigators who haven’t received an NIH regular research grant before, the agency also awarded 12 “NIH Director Pioneer Awards,” given to support scientists at any career stage.

###

Media Contact: Debra Kain, 619-543-6163, ddkain@ucsd.edu



Media Contact

Related News

4/22/2015
UC San Diego Health System and Scripps Health are partnering to provide improved continuity of patient care, fellowship training and research in hospice and palliative medicine. Under a new five-year ...
4/20/2015
Researchers at the University of California, San Diego School of Medicine and Moores Cancer Center have discovered a molecular mechanism that connects breast tissue stiffness to tumor metastasis and p ...
4/20/2015
A decrease in the amount of time spent eating and an increase in overnight fasting reduces glucose levels and may reduce the risk of breast cancer among women, report University of California, San Die ...
4/20/2015
The threat of falsified medications, also referred to as counterfeit, fraudulent, and substandard, can be quite real, yet the full scope and prevalence of the problem is poorly understood, say researc ...
4/17/2015
Researchers at the University of California, San Diego School of Medicine have created an in vitro, live-cell artificial vessel that can be used to study both the application and effects of devices us ...
4/16/2015
The increase in use of e-cigarettes has led to heated debates between opponents who question the safety of these devices and proponents who claim the battery-operated products are a useful cessation t ...
4/16/2015
An international team of scientists, led by researchers at University of California, San Diego School of Medicine, have found genetic overlap between Alzheimer’s disease (AD) and two significant cardi ...
4/13/2015
About one quarter of all atrial fibrillation patients at the lowest risk for stroke receive unnecessary blood thinners from cardiology specialists, according to a new study by researchers at Universit ...